禾信仪器(688622) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥46,145,119.76, a decrease of 49.66% compared to the same period last year[2] - The net profit attributable to shareholders for Q3 2024 was -¥91,679.60, with a year-to-date net profit of -¥22,152,762.73[2] - Total operating revenue for the first three quarters of 2024 was CNY 149,465,372.87, a decrease of 40% compared to CNY 249,459,184.41 in the same period of 2023[15] - Net profit for the third quarter of 2024 was CNY -25,710,018.92, compared to CNY -59,285,289.01 in the same quarter of 2023, indicating an improvement[16] - The total comprehensive income for the period was -25,710,018.92 CNY, compared to -59,285,289.01 CNY in the same period last year[17] - Basic and diluted earnings per share were both -0.32 CNY, an improvement from -0.79 CNY in the previous year[17] Cash Flow - The net cash flow from operating activities for Q3 2024 was ¥1,318,800.18, reflecting a decrease of 96.38% year-on-year[2] - Cash flow from operating activities showed a net outflow of -24,757,943.71 CNY, compared to -60,776,290.40 CNY in the same period last year[18] - Cash inflow from investment activities was 82,115,291.10 CNY, while cash outflow was 136,214,402.47 CNY, resulting in a net cash outflow of -54,099,111.37 CNY[18] - Cash flow from financing activities resulted in a net outflow of -4,192,384.83 CNY, contrasting with a net inflow of 99,057,840.23 CNY in the previous year[19] - The ending balance of cash and cash equivalents was 72,921,609.43 CNY, down from 188,273,562.59 CNY at the end of the previous year[19] - The company reported cash payments to employees of ¥46,322,311.05 in 2024, a decrease from ¥102,697,078.54 in 2023, indicating a reduction in workforce costs[28] Assets and Liabilities - Total assets at the end of Q3 2024 were ¥970,071,747.77, a decrease of 10.27% from the end of the previous year[3] - The company's current assets totaled CNY 420,010,748.93, down from CNY 555,441,781.70 at the end of 2023, indicating a decline of approximately 24.4%[12] - The total liabilities decreased to CNY 576,588,462.44 in Q3 2024 from CNY 663,450,016.66 in Q3 2023, reflecting a reduction of approximately 13.1%[14] - The total equity attributable to shareholders decreased to CNY 414,608,304.65 in Q3 2024 from CNY 435,255,984.38 in Q3 2023[14] - The total current liabilities were reported at CNY 169,150,000.00, down from CNY 191,975,100.00, indicating a decrease of about 11.0%[12] Research and Development - Total R&D investment for Q3 2024 was ¥5,799,562.54, down 65.33% from the previous year, representing 12.57% of operating revenue[3] - Research and development expenses for the first three quarters of 2024 were CNY 25,196,793.75, a reduction of 53% from CNY 53,946,852.58 in 2023[15] - Research and development expenses decreased to CNY 19.50 million in the first three quarters of 2024, a reduction of 53.8% compared to CNY 42.15 million in the same period of 2023[24] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 2,581[8] - Major shareholder Zhou Zhen holds 20.87% of the shares, totaling 14,609,675 shares[8] Government Support - The company received government subsidies amounting to ¥6,892,427.11 during the reporting period[4] Strategic Adjustments - The company reported a significant reduction in losses due to strategic adjustments in resource allocation and cost control measures[7] - The company has not reported any significant new product developments or technological advancements during the quarter[10] - There were no changes in the top 10 shareholders or their participation in margin trading activities[10] - The company has not disclosed any new strategies related to market expansion or mergers and acquisitions in this reporting period[10] Financial Ratios - The weighted average return on equity was -0.02% for Q3 2024, compared to -5.22% year-to-date[2]